Ln(III) complexes with chromone-3-carbaldehyde-(2´-hydroxy)benzoyl hydrazone as the Schiff base ligand have been synthesised and characterised by elemental analysis, molar conductivity, 1 H NMR, mass spectra, UV-Vis spectra, and IR spectra. Electronic absorption spectra, fluorescence spectra, ethidium bromide displacement experiments and viscosity measurements indicate that the free ligand and its Ln(III) complexes, especially the La(III) complex, bind strongly to calf thymus DNA via an intercalation mechanism. The intrinsic binding constants of the free ligand, La(III) complex, Sm(III) complex and Er(III) complex with DNA were (2.20±0.12) × 10 5 M -1 , (8.83±0.04) × 10 6 M -1 , (7.35±0.07) × 10 6 M -1 and (3.24±0.04) × 10 6 M -1 , respectively. Furthermore, the antioxidant activity of the ligand and its Ln(III) complexes was determined by the superoxide and hydroxyl radical scavenging method in vitro, which indicates that the ligand and its Ln(III) complexes are efficient antioxidants and the Ln(III) complexes exhibit more effective antioxidant activity than the free ligand alone and some standard antioxidants, such as mannitol and vitamin C.
www.prkm.co.uk preventing the proper relaxation of DNA. Moreover, DNA-targeting cancer drugs continue to be developed, as evidenced by the approval of belotecan [2, 3] . Basically, metal complexes interact with double helix DNA in either a noncovalent or covalent way, and the former includes three binding modes, i.e. intercalation, groove binding and external static electronic effects [4] [5] [6] . Among these interaction modes, intercalation is the most important DNA binding mode. DNA intercalators, such as cisplatin, have been extensively used as antitumour, antineoplastic, antimalarial, antibiotic, and antifungal agents. Moreover, the DNA intercalation binding mode has been widely studied and numerous biological experiments have demonstrated that DNA is the primary intracellular target of anticancer drugs due to the intercalation between small molecules and DNA, which can cause DNA damage in cancer cells, blocking their division and resulting in cell death [7, 8] . So to develop new and efficient DNA intercalators to be used as anticancer drugs is an urgent and important task. Chromones (1-benzopyran-4-one), such as flavonoids and chromone compounds, are oxygen-containing heterocyclic compounds with a benzo-annelated γ-pyrone ring. They are a group of naturally and widely distributed compounds which are ubiquitous in nature, especially in the plant kingdom [9] . They have received considerable attention in the literature recently, mainly due to their biological and physiological activities including antimycobacterial, antifungal, anticonvulsant, antimicrobial, mushroom tyrosinase inhibition activities, intermediates to many products of fine chemical industries [10] [11] [12] , etc. In addition, some hydrazones and their metal complexes often have diverse biological and pharmaceutical activities, such as antimicrobial, antituberculostatic, anticancer, antioxidant properties, etc [13] . Furthermore, Schiff-bases are also able to inhibit the growth of several animal tumours, and some chelates have shown good antitumour activities, and the lanthanide ions, such as La 3+ , Sm 3+ and Er 3+ , affect antitumour activity greatly [14] . On the other hand, biomolecules, such as DNA, lipids and proteins, can be oxidatively damaged by the over-production of activated oxygen species in the forms of superoxide anion (O 2 -• ) and hydroxyl radical (HO • ), generated by normal metabolic processes [15] [16] [17] , and consequently cancer, aging, inflammation, cardiovascular and neurodegenerative diseases can be induced [18] [19] [20] . The potential value of antioxidants has already prompted investigators to search for the cooperative effects between metal complexes and natural compounds for improving antioxidant activity and cytotoxicity [21, 22] . In our previous work, metal complexes derived from Schiff bases based on chromones have been reported and all these free ligands and their metal complexes can strongly interact with DNA via an intercalation binding mechanism [23, 24] . Moreover, they also exhibited more efficient antioxidant activity in scavenging superoxide anion and hydroxyl radical than common antioxidants, such as mannitol and vitamin C. In this regard, as a development, a novel Schiff base ligand, chromone-3-carbaldehyde-(2´-hydroxy) benzoyl hydrazone and its La(III), www.prkm.co.uk Sm(III) and Er(III) complexes have been synthesised and characterised. In addition, their DNA binding modes and affinities have been investigated systematically. Furthermore, the antioxidant activities of the ligand and its Ln(III) complexes were determined by superoxide anion and hydroxyl radical scavenging methods in vitro. This continuing research on designing new ligands and metal complexes may help us investigate the DNA binding mechanism of chromone derivatives and more efficient antioxidants, and we hope that our research will be widely applied in biology and medicine in the future.
EXPERIMENTAL

Materials and instrumentation
Nitroblue tetrazolium (NBT), methionine (MET), vitamin B 2 (VitB 2 ), EB and calf thymus DNA (CT DNA) were purchased from Sigma Chemical Co. Ethylenediaminetetraaceticacid (EDTA), safranin, o-hydroxybenzoyl hydrazine, Ln(NO 3 ) 3 •6H 2 O [Ln(III) = La, Sm and Er] were produced in China. All chemicals used were of analytical grade. EDTA-Fe(III) and KH 2 PO 4 -Na 2 HPO 4 buffers were prepared with doubly-distilled water. All experiments involving the interaction of the ligand and its Ln(III) complexes with CT DNA were carried out in doubly-distilled water buffer containing 5 mM Tris [Tris(hydroxymethyl)-aminomethane] and 50 mM NaCl which were adjusted to pH 7.10 with hydrochloric acid. Solution of CT DNA in tris-HCl buffer gave ratios of UV absorbance of about 1.8-1.9:1 at 260 and 280 nm, indicating that the CT DNA was sufficiently free of protein [25] . The CT DNA concentration per nucleotide was determined spectrophotometrically by employing an extinction coefficient of 6600 M -1 cm -1 at 260 nm [26] . The ligand and its complexes were dissolved in a solvent mixture of 1% DMF and 99% Tris-HCl buffer (pH 7.10) at a concentration of 1.0×10 -5 M. Carbon, hydrogen and nitrogen were determined using an Elemental Vario EL analyser. The metal contents of the complexes were determined by titration with EDTA (xylenol orange tetrasodium salt used as an indicator and hexamethylidynetetraimine as buffer). The melting point of the ligand was determined on a Beijing XT4-100X microscopic melting point apparatus (the thermometer was not corrected). The IR spectra were obtained in KBr discs on a Therrno Mattson FTIR spectrophotometer in the 4000-400 cm -1 region. 1 H NMR spectra were recorded on a Varian VR 300 MHz spectrometer in DMSO-d 6 with TMS (tetramethylsilane) as internal standard. Mass spectra were performed on an APEX II FT-ICR MS instrument using methanol as mobile phase. All conductivity measurements were performed in DMF solution with a DDS-11C conductometer at 25.0 o C. UV-Vis spectra were recorded on a Shimadzu UV-240 spectrophotometer. Fluorescence measurements were recorded on a Hitachi RF-4500 spectrofluorophotometer at room temperature. The antioxidant activity experiments were performed in DMF solution with a 721-E spectrophotometer.
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Preparation of the ligand (L) and its Ln(III) complexes
Preparation of the ligand (L)
The scheme of the synthesis of the ligand is shown in Figure 1 . 3-Carbaldehyde chromone was prepared according to the literature [27] . An ethanol solution containing o-hydroxybenzoyl hydrazine (1.52 g, 10 mmol) was added dropwise to another ethanol solution containing 3-carbaldehyde chromone (1.74 g, 10 mmol). The mixed solution was refluxed on an oil bath for 8 h with stirring and a large number of precipitates formed. The precipitates were filtered, washed several times with ethanol and recrystallised from DMF and water to give the ligand (L), which was dried in vacuo. 
Preparation of Ln(III) complexes
The ligand (1.0 mmol, 0.308 g) and La(III) nitrate (1.0 mmol, 0.434 g) were added together in ethanol (20 mL 
DNA binding studies
Electronic absorption titration
Electronic absorption titration experiments were performed with a fixed concentration of drugs (10 µM), while gradually increasing the concentration of CT DNA. When measuring the absorption spectra, an equal amount of CT DNA was added to both the complex solutions and the reference solution to eliminate the absorbance of CT DNA itself. Each sample solution was scanned in the range of 190-500 nm.
Fluorescence spectra
To compare quantitatively the affinity of the compounds bound to DNA, the binding constant (K b ) values of the compounds to DNA were obtained by the luminescence titration method. Fixed amounts of compound were titrated with increasing amounts of DNA, over a range of DNA concentrations from 2.5 to 15 µM. Excitation wave lengths of about 302 nm for the ligand and its Ln(III) complexes were used, and fluorescence emission intensities were monitored at ca408 nm. The concentration of the bound compound was calculated using the following equation [28] .
where C t is the total concentration of compound F is the observed fluorescence emission intensity at given a DNA concentration, F 0 is the intensity in the absence of DNA, and F max is the fluorescence of the totally bound compound. Binding data were cast into the form of a Scatchard plot of r/C f versus r, where r is the binding ratio C b /[DNA] t and C f is the free compound concentration. All experiments were conducted at room temperature in a buffer containing 5mM Tris-HCl (pH 7.10) and 50 mM NaCl concentrations. Further support for the binding of the ligand and complexes to DNA via intercalation was given through the emission quenching experiment. EB is a common fluorescent probe for DNA structure and has been employed in examinations of the mode and process of binding of metal complexes to DNA [41] . A 2.0 mL solution of 4 µM DNA and 0.32 µM EB (at saturating binding levels) was titrated by 2.5 -35 µM concentrations of the complexes and ligand. Quenching data were analysed according to the Stern−Volmer equation which could be used to determine the www.prkm.co.uk fluorescent quenching mechanism:
where F o and F are the fluorescence intensities in the absence and presence of drug at [Q] concentration respectively; K q is the quenching constant and [Q] is the quencher concentration. Plots of F o /F versus [Q] appear to be linear and K q depends on temperature [29] .
Viscosity measurements
Viscosity experiments were conducted on an Ubbelodhe viscometer, immersed in a thermostatted water-bath maintained to 25.0 o C. Titrations were performed for the complexes (0.5-4 µM), and each compound was introduced into a DNA solution (5 µM) present in the viscometer. Data were presented as (η/η 0 ) 1/3 versus the ratio of the concentration of the compound and DNA, where η is the viscosity of DNA in the presence of the compound and η 0 is the viscosity of DNA alone [30, 31] .
Antioxidant activity
In antioxidant activity experiments, the superoxide radicals (O 2
•-) were produced by the system MET/VitB 2 /NBT [32] . The amount of O 2
•-and suppression ratio for O 2
•-can be calculated by measuring the absorbance at 560 nm, because NBT can be reduced quantitatively to blue formazan by O 2
•-. The solutions of MET, VitB 2 and NBT were prepared in the dark with 0.067 M phosphate buffer (pH = 7. •-was calculated from the following expression:
where A i = the absorbance in the presence of the ligand or its complexes, A 0 = the absorbance in the absence of the ligand or its complexes. In antioxidant activity experiments involving the hydroxyl radical (HO • ) in aqueous media, it was generated through the Fenton reaction [33] . The solutions of the test compounds were prepared in DMF. The reaction mixture contained 2. The antioxidant activity was expressed as the 50% inhibitory concentration (IC 50 ). IC 50 values were calculated from regression lines where: x was the test compound concentration in µM and y was the percent inhibition of the test compounds.
RESULTS AND DISCUSSIONS
Characterisation of the Ln(III) complexes
The Ln(III) complexes were prepared by the direct reaction of the free ligand with the appropriate mole ratios of Ln(III) nitrate in ethanol solution, and their yields were good to moderate. The Ln(III) complexes were then separated from the solution by filtration, and purified by the mass ethanol washing method. The Ln(III) complexes are quite air-stable for extended periods and easily soluble in N,N-dimethylformamide (DMF) and dimethyl sulfoxide (DMSO) solution, slightly soluble in ethanol, methanol and chloroform solution; insoluble in benzene, water and diethyl ether. The molar conductivities of the Ln(III) complexes are in the range of 105-113 S cm 2 mol −1 in DMF solution, showing that the Ln(III) complexes are all 1:1 electrolytes [34] . The investigation of IR spectra is an important method to gain structural information about metal complexes. All the spectra were characterised by vibrational bands mainly due to the C=O, C=N, M-O, M-N and NO 3 groups. For the free ligand, the characteristic O-H peak appeared at 3245 cm -1 , while for the Ln(III) complexes, the ν O-H vibrations of the Ln(III) complexes were also at about 3245 cm -1 , indicating that the hydroxyl group in the Schiff base ligand did not coordinate with the Ln(III) ions. The ν (carbonyl)C=O and ν (hydrazonic)C=O vibrations of the free ligand appeared at 1655 and 1623 cm -1 , respectively. For the La(III) complex, its ν (carbonyl)C=O and ν (hydrazonic)C=O peaks appeared at 1639, 1618 cm -1 respectively. For Sm(III) complex, the ν (carbonyl)C=O and ν (hydrazonic)C=O peaks were at 1642 and 1616 cm -1 respectively. For Er(III) complex, the peaks at 1637 and 1618 cm -1 could be assigned to ν (carbonyl)C=O and ν (hydrazonic)C=O . In the Ln(III) complexes, the band at ca606 cm -1 is assigned to ν M-O , demonstrating that the oxygen atoms of the (carbonyl)C=O and (hydrazonic)C=O groups have formed a coordinative bond with the Ln(III) ions [35] . The different shifts of the wavenumbers indicate that the Ln-O (carbonyl) bond is a little stronger than the Ln-O (hydrazonic) bond. The band at 1566 cm -1 for the free ligand is assigned to ν C=N stretch, which shifts to about 1588 cm -1 for the Ln(III) complexes, and Δν (ligand-complexes) is equal to 22 cm -1 . Weak bands at ca 501 cm -1 for the Ln(III) complexes are assigned to ν M-N , www.prkm.co.uk indicating that the nitrogen of the imino-group bonds to the Ln(III) ions [36] . The absorption bands of the coordinated nitrates were observed at about 1461 (ν as ) and 865 (ν s ) cm -1 . The ν 3 (E′) free nitrates appeared at 1388 cm -1 in the spectra of the rare earth complexes. In addition, the separation of the two highest frequency bands xν 4 -ν 1 x is approximately 241 cm -1 , and accordingly the coordinated NO 3 -anion in the Ln(III) complexes is a bidentate ligand [37] . The study of the electronic spectra in the UV-Vis ranges for the free ligand and Ln(III) complexes was carried out in a buffer solution containing 5 mM TrisHCl (pH 7.10) and 50 mM NaCl concentrations. The electronic spectra of the free ligand have a strong band at λ max = 269 nm and a medium band at λ max = 306 nm. The Ln(III) complexes also yield two bands which are shifted to ca277 and 301 nm. These indicate that the Ln(III) complexes are formed. The electrospray ionisation (ESI) mass spectra of the La(III) complex were measured; they showed peaks at 879, which can be assigned to the fragment [La(III) complex -NO 3 ] + . In summary, the novel ligand and La(III), Sm(III), Er(III) ions can form mononuclear ten-coordination [LnL 2 ·(NO 3 ) 2 ]NO 3 [Ln(III) = La, Sm and Er, L is chromone-3-carbaldehyde-(2'-hydroxy) benzoyl hydrazone] complexes with 1:2 metal-to-ligand stoichiometry at the Ln(III) centres based on the investigations of elemental analysis, molar conductivity, 1 H NMR, mass spectra, UV-Vis spectra, and IR spectra.
DNA binding properties
Electronic absorption titration
Before reacting the ligand and its Ln(III) complexes with CT DNA, their solution behaviour in buffer solution at room temperature was monitored by UV-Vis spectroscopy for 24 h. Liberation of the ligand and its complexes was not observed under these conditions. This suggests that the ligand and its complexes are stable under the conditions utilised. The binding abilities of the ligand and Ln(III) complexes with CT DNA can be characterised by measuring their effects on the UV-Vis spectra. The electronic absorption spectra of the free ligand and its Ln(III) complexes in the absence and presence of CT DNA are given in Figure 2 . As shown, in the presence of DNA, the absorption bands of the free ligand, La(III), Yb(III) and Er(III) complexes at about 306 nm exhibited hypochromism of 36.30%, 56.54%, 54.70% and 50.24%, respectively. The hypochromism observed for the Ln(III) complexes are all accompanied by a redshift of about 3 nm. The intercalative mode of binding usually results in hypochromism and a redshift because of the strong stacking interaction between an aromatic chromophore and DNA base pairs. The extent of the spectral change is related to the strength of binding [38] . After compounds intercalate DNA base pairs, the π* orbital of the intercalated compound can couple with the π orbital of DNA base pairs, thus decreasing the π→π* transition energy and resulting in www.prkm.co.uk the bathochromism. On the other hand, the coupling π orbial is partially filled by electrons, thus decreasing the transition probalities and concomitantly resulting in the hypochromism [39] . The electronic absorption spectra of the free ligand and its Ln(III) complexes indicated that these compounds can interact with DNA via the intercalation binding mode, and the Ln(III) complexes bind to DNA more strongly than the free ligand alone. EB (a typical indicator of intercalation) quenching assay was performed to test further the binding modes of DNA towards these investigated compounds [40] . Figure 3 shows the electronic absorption spectra when EB was employed. Curve A in Figure 3 is the spectrum of tris-HCl buffer solution, which is the most intense when there is only EB, and the maximum wavelength is at 479 nm. After adding CT DNA into the buffer solution, the absorbance decreases, as seen in curve C. Curve (B) in Figure 3 shows the absorption of a mixed solution of EB, DNA and the prepared compound, such as the free ligand, La(III), Sm(III) or Er(III) complex in tris-HCl buffer solution. The absorption has increased in comparison with curve C. In addition, the wavelength shifts to 494 nm. All these phenomena are characteristic of the intercalation binding mode. These may result from two reasons: (1) EB is strongly bound to the free ligand and metal complexes, www.prkm.co.uk resulting in the decrease of the amount of EB intercalated into DNA; (2) there exists competitive intercalation between the free ligand and metal complexes and EB with DNA, so releasing some free EB from the DNA-EB system. However, the former reason could be precluded because there were no new absorption peaks appearing. Thus, we can conclude that the free ligand and its Ln(III) complexes can displace EB from its DNA-EB system via the intercalation mode. www.prkm.co.uk than the free ligand alone. Since the hydrophobic environment inside the DNA helix reduces the accessibility of solvent water molecules to the compound, and the compound mobility is restricted at certain binding sites, a decrease of the vibrational modes of relaxation results. The binding of the compounds to DNA leading to a significantly increase in emission intensity also agrees with those observed for other intercalators [41] . As seen from K b values of the ligand and its Ln(III) complexes, the Ln(III) complexes bind to DNA more strongly and deeply than the free ligand alone. The higher binding affinities of the Ln(III) complexes are probably attributable to the extension of the π system of the intercalated ligand due to the coordination of transition metal ions, which also leads to a planar area greater than that of the free ligand, and the coordinated ligand penetrating more deeply into, and stacking more strongly, with the base pairs of DNA. Binding modes and affinities of the compounds with DNA were further monitored by a fluorescent EB displacement assay. EB is one of the most sensitive fluorescence probes that can bind to DNA and the fluorescence of EB increases after intercalating into DNA base pairs [42] . The fluorescence intensity of EB increases after intercalating into DNA base pairs. When the compounds intercalate with DNA, the competitive binding of other drugs to the DNA and EB system will result in a decrease in the fluorescence intensity of the DNA-EB system. Also, the reduction of the fluorescence intensity is important evidence for studying the DNA binding propensity of the compounds and the stacking interaction (intercalation) between the adjacent DNA base pairs [43] . Figure 5 shows the emission spectra of the DNA-EB system with increasing amounts of the metal complexes and free ligand. 
Fluorescence spectra
Viscosity measurements
Viscosity titration experiments were carried out to clarify the nature of the interaction of the compounds and DNA. Hydrodynamic measurements, such as viscosity and sedimentation measurements, are very sensitive to changes in the length of DNA, as viscosity is proportional to L 3 for rod-like DNA of length L, and viscosity measurements are regarded as the least ambiguous and one of the most critical tests of a binding model in solution in the absence of crystallographic structural data [44] . The classical intercalation model requires that the DNA helix must lengthen as its base pairs are separated to accommodate the binding complexes, www.prkm.co.uk www.prkm.co.uk leading to the increase of DNA viscosity, as for the behaviours of known DNA intercalators. In contrast, a partial and/or non-classical intercalation of the complex could bend (or kink) the DNA helix, reducing its viscosity concomitantly [45] . In addition, some compounds such as [Ru(bpy) 3 ] 2+ , which interacts with DNA by an electrostatic binding mode, have no influence on DNA viscosity [46] . To elucidate further the binding mode of the compounds, viscosity measurements were carried out by keeping [DNA] = 5 µM and varying the concentration of the compounds. The effects of the free ligand and its Ln(III) complexes on the viscosity of CT DNA are plotted in Figure 6 . It can be seen that the viscosities of DNA increase steadily with increasing concentrations of the free ligand and its Ln(III) complexes, and the extent of the increase for the free ligand is smaller than that of its Ln(III) complexes. These results suggest that the free ligand and its Ln(III) complexes intercalate into the DNA base pairs, causing an extension in the DNA helix and thus increasing the viscosity of DNA, and that the complexes can intercalate more strongly and deeply than the free ligand, leading to the greater increase in viscosity of the DNA with an increasing concentration of the complexes. The results obtained from the viscosity experiments validate those obtained from the above spectroscopic studies.
On the basis of all the spectroscopic studies together with the viscosity measurements, we find that the free ligand and its Ln(III) complexes interact with CT DNA via the intercalation binding mechanism ( Figure 7 ) and the Ln(III) complexes intercalate into the DNA base pairs more strongly and deeply than the free ligand alone. www.prkm.co.uk obtained has proved that the oxidation induced by ROS is involved in the pathogenesis of various diseases through effects on DNA directly and by acting as a tumour promoter [47] . Thus, antioxidant activity of the free ligand and its Ln(III) complexes was studied by comparing their scavenging effects on superoxide anion and hydroxyl radicals systematically. The inhibitory effects of the free ligand and its Ln(III) complexes on O 2 •-(a) and HO • (b) are shown in Figure 8 . The antioxidant activity of the compounds is expressed as the 50% inhibitory concentration (IC 50 in µM). From Figure 8(a) , the average suppression ratio for O 2
Antioxidant activity
•-increases with increasing concentration of the compound in the range of tested concentrations. The average suppression ratio (IC 50 values) of the ligand, La(III), Sm(III) and Er(III) complexes are 382.54, 2.92. 13.52 and 37.83 µM, respectively. It is clear that the scavenger effect on O 2
•-is enhanced by the formation of metal-ligand coordination compounds, and the nature of the metal ions also has a different and selective nature for scavenging O 2
•-. As seen from Figure 8b , the inhibitory effect of all the compounds is marked and the average suppression ratio for HO • increases with increasing concentrations of the compounds. The IC 50 value of the free ligand is 234.72 µM, which is the weakest in all the compounds. The antioxidant activity of La(III) complex (IC 50 = 7.22 µM) for scavenging HO • is the best. All these results indicate the scavenger effects www.prkm.co.uk can be enhanced due to the formation of coordination compounds, and the metal ions also affect the scavenger ability greatly. Mannitol is usually used as a specific scavenger for HO • [48] , and the IC 50 value of ascorbic acid (vitamin C, a standard agent for non-enzymatic reactions) for HO • is 1.537 mg mL -1 (8.727 mmol), and the scavenging effect for O 2 •-is only 25% at 1.75 mg mL -1 (9.94 mmol) [49] . We found the Ln(III) complexes are better inhibitors than the standard antioxidants, such as mannitol and vitamin C. It is believed that the information obtained from the present work will be useful in developing new potential antioxidants and therapeutic agents for certain diseases.
CONCLUSION
In summary, a new Schiff base ligand, 3-carbaldehyde-(2'-hydroxy) benzoyl hydrazone, and its La(III), Sm(III) and Er(III) complexes have been prepared and characterised by elemental analysis, molar conductivity, 1 H NMR, mass spectra, UV-Vis spectra, and IR spectra. Their DNA binding properties and antioxidant activities were studied systematically. The results indicate that the ligand and its Ln(III) complexes can bind to DNA via an intercalation binding mode and the Ln(III) complexes have better DNA binding affinity than the free ligand alone. Furthermore, the Ln(III) complexes, especially the La(III) complex have more active scavenging effects on O 2
•-and HO • than the standard antioxidants, such as mannitol and vitamin C. Our work clearly indicates that the Ln(III) complexes have many potential practical applications, such as understanding the mechanisms of interaction between compounds and DNA, and the development of potential anticancer drugs and new antioxidants.
